Singular Genomics Systems, Inc.

NASDAQ:OMIC

23.3 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -94.82-90.879-98.771-27.945-12.324
Depreciation & Amortization 7.2236.0321.1330.6390.35
Deferred Income Tax 0.78204.1390.2810
Stock Based Compensation 11.40413.6699.2311.060.17
Change In Working Capital -2.245-16.817-2.9110.8580.415
Accounts Receivables 0.348-0.913000
Inventory -3.537-13.487000
Accounts Payables 0.267-1.1681.854-0.1480.244
Other Working Capital 2.922-1.249-4.7651.0060.171
Other Non Cash Items 4.0090.90135.4780.234-0.01
Operating Cash Flow -73.647-87.094-51.701-24.873-11.399
Investing Activities:
Investments In Property Plant And Equipment -0.97-6.022-4.864-1.38-0.8
Acquisitions Net 033.544125.997-25.38530.7
Purchases Of Investments -183.595-174.713-195.684-6.077-42.729
Sales Maturities Of Investments 198.372141.16969.68731.46212.029
Other Investing Activites 0-33.544-125.99725.385-30.7
Investing Cash Flow 13.807-39.566-130.86124.005-31.5
Financing Activities:
Debt Repayment 00-10.4-7.5-2.464
Common Stock Issued 0.0131.351240.7760.0170.041
Common Stock Repurchased -0.019-0.453.577-0.002-0.021
Dividends Paid 00000
Other Financing Activities 0.7020.901141.7527.51552.191
Financing Cash Flow 0.6960.901372.1287.51547.304
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -59.144-125.759189.5666.6474.405
Cash At End Of Period 16.83375.977201.73612.175.523